Wu Siwei, Smith Alexander, Huang Jingxian, Otto Georg W, Ko Yi-Hsuan, Yarmolinsky James, Gill Dipender, Rohatgi Anand, Dehghan Abbas, Tzoulaki Ioanna, Meena Devendra
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
medRxiv. 2024 Dec 18:2024.12.18.24319223. doi: 10.1101/2024.12.18.24319223.
South Asians are at higher risk of dyslipidaemia-a modifiable risk factor for cardiovascular diseases (CVDs). We aimed to identify protein targets for dyslipidaemia and CVDs in this population. We used a two-sample Mendelian randomization (MR) approach, supplemented with MR-Egger, weighted median, colocalization, and generalized MR (GMR), to evaluate the effect of 2,800 plasma proteins on high/low/non-high-density lipoprotein cholesterol (HDL-C/LDL-C/nonHDL-C), total cholesterol, and triglycerides. Observational analyses were conducted on MR findings with strong colocalization (posterior probability≥ 80%) and GMR findings. Univariate MR assessed lipid-associated proteins' effect on CVDs. Finally, we compared the potential causal effects of plasma proteins on lipids in South Asians with those in Europeans to study heterogeneity in the MR effects. We identified 29 genetically proxied proteins potentially causal to at least one lipid measure, 12 of which showed strong colocalization and GMR evidence, including ANGPTL3 and PCSK9. Notably, PCSK9 demonstrated a stronger association with LDL-C in European compared to South Asian (β= 0.37; 95% Confidence Interval (CI)= (0.36, 0.38), β Asian= 0.16; 95% CI= (0.11, 0.21)). Observational analysis suggested significant interaction between PCSK9 levels with LDL-C levels in South Asians with South Asians having a significantly lower effect compared to other ethnicities (PCSK9*South Asian; β= -0.14; 95% CI= (-0.174, -0.107)). Additionally, we showed that CELSR2 is also linked with CAD in South Asians. Our study highlighted potential causal links between plasma proteins, dyslipidaemia, and CVD in South Asians, with significant heterogeneity across genetic ancestry groups. Larger studies in South Asians are needed to validate these findings.
南亚人患血脂异常的风险较高,而血脂异常是心血管疾病(CVD)的一个可改变的风险因素。我们旨在确定该人群中血脂异常和心血管疾病的蛋白质靶点。我们采用两样本孟德尔随机化(MR)方法,并辅以MR-Egger、加权中位数、共定位和广义MR(GMR),以评估2800种血浆蛋白对高/低/非高密度脂蛋白胆固醇(HDL-C/LDL-C/非HDL-C)、总胆固醇和甘油三酯的影响。对具有强共定位(后验概率≥80%)的MR结果和GMR结果进行观察性分析。单变量MR评估脂质相关蛋白对心血管疾病的影响。最后,我们比较了血浆蛋白对南亚人和欧洲人脂质的潜在因果效应,以研究MR效应中的异质性。我们确定了29种基因代理蛋白可能对至少一种脂质指标具有因果关系,其中12种显示出强共定位和GMR证据,包括ANGPTL3和PCSK9。值得注意的是,与南亚人相比,PCSK9在欧洲人与低密度脂蛋白胆固醇的关联更强(β=0.37;95%置信区间(CI)=(0.36,0.38),南亚人β=0.16;95%CI=(0.11,0.21))。观察性分析表明,南亚人PCSK9水平与低密度脂蛋白胆固醇水平之间存在显著相互作用,与其他种族相比,南亚人的影响显著较低(PCSK9*南亚人;β=-0.14;95%CI=(-0.174,-0.107))。此外,我们还表明CELSR2也与南亚人的冠心病有关。我们的研究强调了血浆蛋白、血脂异常和南亚人心血管疾病之间潜在的因果联系,不同遗传血统群体之间存在显著异质性。需要在南亚人身上进行更大规模的研究来验证这些发现。